Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:22 AM

Published 11/06/2009 by Engadget


Sensium wireless digital band-aid begins clinical trials

It hasn't been a year since , and now clinical trials have begun for Sensium. Billed as a 'digital plaster,' the thin patch contains a power source and sensors for monitoring heart rate, temperature, and perspiration -- all of which can then be sent to...

Share this 

What others report on the same story

Quotes

...commented: "This technology has the potential to improve the capturing of patient's vital signs within all areas of the hospital - enabling key physiological data to be acquired at an increased frequency, with the minimum of inconvenience to patients, and without the requirement to connect patients to immobile pieces of equipment. This raises the possibility of technology improving hospital safety systems enhancing the efficiency of adding vital sign data to patient records and potentially freeing valuable nursing staff time for other patient care responsibilities." Professor Chris Toumazou...
...commented: "It is fantastic to see the Sensium technology coming to fruition, and for us to be launching this study at Imperial College Healthcare NHS Trust. This is a key stage in our commercial journey and one that opens the door to some very exciting applications of our technology in clinical environments next year. 'The business case is simple: by using the disposable digital plaster to monitor on a 24-7 basis, critical medical information can be monitored that would not otherwise have been detected. This preventative form of medicine will mean that less people could require intensive care in the future, saving lives and at the same time providing greater efficiencies and cost savings to the NHS. Once proven in a hospital setting then the digital plaster can be deployed in the home in the same way.' * Ends -"

Related Stories

First Reported 11/12/2009 - Updated 11/12/2009 - 1 Documents
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced the final analyses of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults and children. The data ... [Medical News Today - 11/12/2009]
Network

Blogs

sort by: Date | Relevance
Sensium wireless digital band-aid begins clinic... [Engadget - 11/06/2009]
It hasn't been a year since it was first announced, and now clinical trials have begun for Sensium. Billed as a "digital plaster," the thin patch contains a power ...
One small strip of plaster, one giant strip of ... [CNET News.com - 11/04/2009]
A wireless digital "plaster" that monitors vital signs is being tested on patients and volunteers at Imperial College Healthcare NHS Trust in a new clinical trial ...
Yet Another Qui Tam Grand Slam [WSJ.com: Law Blog - 10/30/2009]
No one likes a nark. But these days, the pharmaceutical industry, it seems, has more reason to fear them than most. Earlier this year, Eli Lilly & Company paid ...
One small strip of plaster, one giant strip of ... [CNET News.com - 11/04/2009]
A wireless digital 'plaster' that monitors vital signs is being tested on patients and volunteers at Imperial College London.(Credit: Toumaz Technology) When you ...
US: Take the shot [H5N1 - 11/05/2009]
Via the New York Times: Editorial - Take the Shot. Excerpt:The swine flu vaccine has encountered a remarkably mixed reception. Some people are railing against their ...
1 2

  •  
  •  
  •